Chromosomal Rainbows detect Oncogenic Rearrangements of Signaling Molecules in Thyroid Tumors
Altered signal transduction can be considered a hallmark of many solid tumors. In thyroid cancers the receptor tyrosine kinase (rtk) genes NTRK1 (Online Mendelian Inheritance in Man = OMIM *191315, also known as 'TRKA'), RET ('Rearranged during Transfection protooncogene', OMIM *164761) and MET (OMIM *164860) have been reported as activated, rearranged or overexpressed. In many cases, a combination of cytogenetic and molecular techniques allows elucidation of cellular changes that initiate tumor development and progression. While the mechanisms leading to overexpression of the rtk MET gene remain largely unknown, a variety of chromosomal rearrangements of the RET or NTKR1 gene could be demonstrated in thyroid cancer. Abnormal expressions in these tumors seem to follow a similar pattern: the rearrangement translocates the 3'-end of the rtk gene including the entire catalytic domain to an expressed gene leading to a chimeric RNA and protein with kinase activity. Our research was prompted by an increasing number of reports describing translocations involving ret and previously unknown translocation partners. We developed a high resolution technique based on fluorescence in situ hybridization (FISH) to allow rapid screening for cytogenetic rearrangements which complements conventional chromosome banding analysis. Our technique applies simultaneous hybridization of numerous probes labeled with different reporter molecules which are distributed along the target chromosome allowing the detection of cytogenetic changes at near megabase-pair (Mbp) resolution. Here, we report our results using a probe set specific for human chromosome 10, which is altered in a significant portion of human thyroid cancers (TC's). While rendering accurate information about the cytogenetic location of rearranged elements, our multi-locus, multi-color analysis was developed primarily to overcome limitations of whole chromosome painting (WCP) and chromosome banding techniques for fine mapping of breakpoints in papillary thyroid cancer (PTC).
- Research Organization:
- Lawrence Berkeley National Lab. (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- Life Sciences Division
- DOE Contract Number:
- DE-AC02-05CH11231
- OSTI ID:
- 1011038
- Report Number(s):
- LBNL-4366E; TRN: US201109%%381
- Country of Publication:
- United States
- Language:
- English
Similar Records
BAC-FISH assays delineate complex chromosomal rearrangements in a case of post-Chernobyl childhood thyroid cancer
Molecular cytogenetic characterization of a human thyroid cancercell line
Related Subjects
BANDING TECHNIQUES
CHROMOSOMES
CULTURAL OBJECTS
DETECTION
DNA
FLUORESCENCE
GENES
HUMAN CHROMOSOMES
HYBRIDIZATION
IN-SITU HYBRIDIZATION
NEOPLASMS
PHOSPHOTRANSFERASES
PROBES
PROTEINS
RESOLUTION
RNA
TARGETS
THYROID
TRANSLOCATION
TYROSINE
receptors
cellular signaling
tumors
genes
human chromosomes
rearrangements
molecular cytogenetics
DNA probes